Christopher P. Cannon, M.D.
Executive Director, Cardiometabolic Trials, Harvard Clinical Research Institute
Senior Physician, Cardiovascular Division, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Dr. Cannon is a professor of medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center, and cardiovascular fellowship at Brigham and Women’s Hospital.
Dr. Cannon has published over 1000 original articles, reviews, or electronic publications in the field of acute coronary syndromes and prevention and has authored or edited 17 books. He recently completed a term as editor-in-chief of American College of Cardiology’s website, www.Cardiosource.org. He has received numerous awards, including leadership awards from the American College of Cardiology and the American Heart Association.
He has been principal investigator of more than 15 multicenter clinical trials, including TACTICS-TIMI 18 and PROVE IT. While completing work on three trials of lipid-modifying strategies, such as IMPROVE IT, Dr. Cannon now serves as Executive Director of Cardiometabolic Trials at the Harvard Clinical Research Institute (HCRI). He is leading the RE-DUAL PCI trial, studying novel anticoagulant strategies in patients with atrial fibrillation undergoing stenting, and collaborates on many other trials and registry projects in the fields of acute coronary syndromes, atrial fibrillation, diabetes, lipids and prevention.